Effect of Mindfulness-based stress reduction and Cognitive behavior Therapy in Rheumatoid Arthritis Patients

Effect of Mindfulness-based stress reduction and Cognitive behavior Therapy on Emotional Strategies, Executive function, Activity of disease, quality of life and sleep in Rheumatoid Arthritis Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181128041778N1

Enrollment

Registered

2019-04-20

Start date

2018-11-22

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: Intervention group: MBSR : Therapeutic intervention is an 8 session that lasts once a week for 90 minutes, during which participants are taught to communicate at an instant, without ju

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosis of RA with arthritis At least six months have passed since the diagnosis of rheumatoid arthritis Age of 18 to 60 years Minimum Cycle Education Diagnosis of other joints

Exclusion criteria

Exclusion criteria: There is another joint disease Drug Addiction Suicidal ideation or suicidal thoughts Abuse of alcohol Absence of more than one session in the treatment of MBSR There are more than two sessions in the treatment of CBT

Design outcomes

Primary

Measure	Time frame
Stress. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: DASS-21.;Depression. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: DASS-21.;Anxiety. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: DASS-21.;Chronic fatigue. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Chronic fatigue syndrome (CFS).;Sleep Quality. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Pittsburgh Sleep Quality Questionnaire (PSQI).;Quality of life. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Short Form Health Survey (SF-36).;Executive functions. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Tower of London test.;Disease activity. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: blood test.	—

Measure

Time frame

Stress. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: DASS-21.;Depression. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: DASS-21.;Anxiety. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: DASS-21.;Chronic fatigue. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Chronic fatigue syndrome (CFS).;Sleep Quality. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Pittsburgh Sleep Quality Questionnaire (PSQI).;Quality of life. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Short Form Health Survey (SF-36).;Executive functions. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: Tower of London test.;Disease activity. Timepoint: Before the intervention, after intervention, three months after the intervention. Method of measurement: blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactshafigheh Yousefi

Kashan University of Medical Sciences

sh.yusefi2012@yahoo.com+98 31 5562 0634

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026